. The present study shows that B-CLL cells, freshly isolated from two patients, were slgM+, slgG-, and slgA-but expressed IgG and IgA transcripts. cDNA cloning and sequencing showed that the VDJ segments associated to y and Q heavy chain transcripts are identical to those from p transcripts, thus showing that B lymphocytes giving rise to CLL cells have undergone isotype switching in vivo. Stimulation of these B-CLL cells through surface CD40 in the HE GENERATION OF functional antibodies is the result of multiple genetic changes at the Ig loci. During B lymphopoiesis, gene segments at the Ig heavy (H) and light (L) chain loci assemble in a defined, ordered manner.'.* This developmental pathway, allows the commitment and the maturation of hemopoietic progenitors cells into B lymphocytes, with functional heavy and light chains, expressing IgM at their ~u r f a c e .~.~ The non-self-reactive low-affinity cells develop further to express sIgD, giving rise to mature B cells, also known as naive or virgin B cells. At a later stage, which is driven by antigen and is T-cell-dependent (referred herein as immunopoiesis), B lymphocytes undergo affinity maturation through somatic mutations and isotype switching. During these distinct stages, B lymphocytes become the target of abnormal development, resulting in diverse forms of leukemia^.^,^ Thus, B-chronic lymphocytic leukemias (B-CLL) could phenotypically be identified in a transition stage between immature sIgM+, sIgD-and mature sIgM+, sIgD+ naive B cells. In this context, B-CLL cells are characterized by a marked increase of resting immature/ mature B cells expressing low quantities of surface Ig, in which the isotype most frequently found is IgM or the combination of IgM and IgD.7 It has been previously reported that B-CLL cells can proliferate and differentiate into Igsecreting cells after in vitro stimulation.' However, it has not been formally shown whether such Ig secretion indeed results from in vivo and/or in vitro B-CLL isotype switching or from the contribution of contaminating normal B lymphocytes within the CLL population. In the present report, by analysis of the cDNA sequences of Ig genes expressed by B-CLL cells from two patients, we show that B lymphocytes that give rise to CLL cells have the capacity to undergo isotype switching and differentiation.
mined by standard isotype-specific enzyme-linked immunosorbent assay (ELISA).~~ Factors. Purified recombinant interleukin-4 (IL-4; lo7 U/mg) and highly purified recombinant IL-IO from Chinese hamster ovarytransfected cells (both from Schering-Plough Research Institute, Kenilworth, NJ) were used at the final concentration of 500 U/mL and 100 ng/mL, respectively.
B-cell cultures. Purified leukemic B cells were cultured in Iscove's medium (Flow Laboratories, Irvine, CA) enriched with S0 pg/mL human transfenin, OS% bovine serum albumin (Sigma), and S pg/mL bovine insulin (all from Sigma Chemical CO, St Louis, MO); and S% selected heat-inactivated fetal calf serum, 100 U/mL penicillin, and 1 0 0 pg/mL streptomycin (all from Flow Laboratories). For activation of B-CLL through the CD40 antigen, leukemic B cells were cultured in the presence of the anti-CD40 MoAb89 presented by a mouse Ltk-cell line stably expressing CDw32 (CDw32 L cells). Briefly, IO5 B-CLL cells were cultured in roundbottom microtiter trays under a final volume of 1 0 0 pL, with S,OOO irradiated (70 Gy) CDw32 L cells and 0.5 pg/mL of anti-CD40 MoAh89. Cytokines were added at the onset of the culture."
RNA preparation and northern blotting. Isolation of total RNA was performed by the method of Chomczynski." Extracted unfractionated RNA (20 pg) was electrophoresed, under denaturing conditions, on 1% agarose gel (stained with ethidium bromide) using the method of LerachI3 and was transferred onto nylon membranes as described by Thomas.14 The blot was hybridized to constant region cDNA probe Cp, Cy, and Ca labeled by 32P using the random priming kit according to manufacturer's instructions (Boehringer, Mannheim, Germany).
Reverse-transcription polymerase chain reaction (RT-PCR) assays. Total RNA (1 @g) was converted into single-stranded cDNA by a standard RT reaction using oligodT,,,.,,, (Pharmacia, LKB, Uppsala, Sweden) and Superscript (RNase H-Moloney murine leukemia virus reverse transcriptase; BRL, Gaithersburg, MD) kit, according to manufacturer's instructions. The PCR was per- A total of 35 cycles of amplification were performed ( I minute at 94°C. 2 minutes at 60°C. and 3 minutes at 72°C). A second round was performed using the same primers. starting with 10 pL of the first round.
For IgH chain. cDNA and PCR were performed as described above. Two rounds of 28 cycles were performed (30 seconds at 94°C. 30 seconds at 60°C. and I minute at 72°C). The primers used in the first round were as follows: S'VH consensus S' TCTGAG-GTGCAGCTGGTGGAGTCTG 3' and Cp, S' GAATTCTCACAG-GGT 3'; Cy. S' AAGTAGTCCTTGACCAGGCAG 3': Ca. 5'
The second round was performed using 10 pL of the first round, using the same primers except for Cy , Cc, and Ca for which more 3' internal primers were used in a seminested fashion: Cy, 5' TTCCCGGGTAGCCAGAAG 3'; Ca. S' CCCGGAGGCATCCTG-GCTGGG 3': and Cc. S' AGCGAGTGGCATTGGAGGGAATGT 3'.
Sourhent blotrirtg m d /tyhrir/i:ofinns. PCR products were transferred to nylon membranes, as previously reported,"' and hybridized with VH probes labeled using the digoxygenin-deoxyuridine triphosphate (dUTP) kit (Boehringer, Mannheim, Germany). The probes used were consensus oligonucleotide sequences to the six Cloning u~td .sc.yrrenring. The products from the RT-PCR were directly cloned, without further processing. by the TA cloning kit as described by the manufacturer (Invitrogen, San Diego, CA)." Sequencing reactions were performed using the Taq DyeDeoxyTermination Cycle sequencing kit (catalog no. 401 150; Applied Biosystems Inc. Roissy. France) and were analyzed on an Applied Biosystems automatic DNA sequencer.
RESULTS
Freshly isolated sIgM', slgG-, slgA-R-CLL cells express y and a herny-chain trclnscripts. As previously described," chain W A S could be detected by Northern analysis (Fig  2) . The majority of the transcripts were p, but significant levels of y and a transcripts could also be detected. Such level of expression of p, 7 , and a, reflecting corresponding mRNA frequency, was indicated by the sensitivity of detection, ie, p > y > a.
Freshly isolated B-CLL cells show p, y, and a transcripts with a unique VDJ region. The expression of IgH genes was further analyzed using an isotype-specific RT-PCR ( Fig  3A) . y and a transcripts could be detected in addition to p and 6 transcripts, confirming the results obtained by Northern analysis. To establish the B-CLL origin of the y and a transcripts, analysis of their VH repertoire was performed. As shown in Fig 3B, after amplification and VH-specific hybridization, the p (450 bp), y (450 bp), and a (550 bp) transcripts expressed by B-CLL FLA or PAS used the same VH family genes. Therefore, whereas the B-CLL cells FLA exclusively expressed a VH3 family gene, PAS only expressed a VH1 family gene, indicating that p, y , and a transcripts originated from the same leukemic clone. Furthermore, we investigated whether the freshly isolated B-CLL cells expressed transcripts showing identical VDJ segments associated to different constant region genes. To this end, the cDNAs corresponding to the p, y , and a transcripts, from B-CLL cells FLA and PAS, were cloned and sequenced. Consistent with the VH repertoire analysis, sequencing data shown in Fig 4A and B showed that p, y , and a heavychain transcripts shared the same VDJ segments, proving that the y and a transcripts expressed by B-CLL cells FLA and PAS is the result of in vivo isotype switching. Comparison and alignment of these sequences to corresponding germline genes, showed little or no somatic mutation, suggesting that the cells did not undergo affinity maturation and selection. levels were measured in day-l4 supernatants in standard ELISAs. The addition of IL-IO resulted in a significant production of IgM, IgG, and IgA (Fig 5) without evidence of IgE secretion (data not shown), suggesting that IL-10 can induce CD40-activated B-CLL cells to differentiate into IgGand IgA-secreting cells. Note that the response of B-CLL to IL-l0 was not as efficient as that of normal B cells; ie, 100 to 1,100 ng/mL of IgG and IgA were detected for B-CLL
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FLA and PAS as compared with 1,000 to 5,000 ng/mL for normal B-cell samples. Therefore, it is conceivable that the defect behind the B-CLL cells FLA and PAS studied herein lies on their incapacity to differentiate in vivo into Ig-secreting cells, rather than their inability to undergo isotype switching. Although such defect can be partly restored by physiological differentiation signals known to operate in normal B lymphocytes, no quantitative correlation is expected between the Ig transcripts observed in vivo and the levels of Ig secreted after in vitro stimulation.
To rule out the possibility that secretion of Igs derived from contaminating normal B lymphocytes, which actively proliferate in the CD40
RT-PCR-amplified cDNAs, corresponding to the y and a transcripts from the CD40-activated B-CLL FLA in the presence of IL-10, were cloned and sequenced. We chose to examine FLA VDJ sequence because of its higher Ig secretion levels, in which the risk of contribution by contaminating normal B cells required to be ruled out. Sequence analysis of the y and a transcripts of stimulated B-CLL FLA cells and p transcripts of freshly isolated B-CLL FLA cells, as shown in Fig 6, showed that VDJ segments were identical, confirming that the secretion of IgG and IgA was of CLL origin.
Expression of IgE by B-CLL cells is the result of isotype switching in vitro. As shown in Figs 3A and B, freshly isolated B-CLL cells FLA and PAS did not express E transcripts, indicating that they did not undergo isotype switching towards IgE in vivo. Therefore, the induction of in vitro isotype switching towards IgE was analyzed after the culture of the B-CLL cells FLA and PAS in the CD40 system in the presence of IL-4. As determined by ELISA experiments shown in Fig 7, after in vitro stimulation, IgM and IgE secretion could be detected, but there was no induction of IgA and IgG secretion (data not shown). To establish, at the molecular level, that the secretion of IgE resulted from in vitro isotype switching, RT-PCR-amplified cDNAs, corresponding to E transcripts from B-CLL cells stimulated in the CD40 system in the presence of IL-4, were cloned and sequenced. As shown in Fig 8, the E heavy-chain transcripts show the same VDJ domain as p, thus showing that B-CLL cells can be induced to switch in vitro.
DISCUSSION
The present report shows at the molecular level that B-CLL cells express isotypes other than IgM, as shown by the presence of p, y, and a heavy chain transcripts showing the same VDJ segments. However, the detection of IgG and IgA transcripts in these B-CLL cells does not discriminate from isotype switching taking place either before or after the malignant transformation event.
On the other hand, although these cells express significant levels of mature y and a heavy-chain transcripts, they do not show cytoplasmic or cell surface expression of mature IgG and surface IgA (data not shown). Because the light chain is not a limiting factor for the assembly of the mature Ig, inasmuch as sIgM can be detected on the cell surface, these data suggest that transcription and translation of these B-CLL cells for IgG and IgA expression may be uncoupled. This apparent impaired translation can be released on cultur- """_""""""-"""""""""""""""- 
IL-4.
IL-l0 does not allow IgG and IgA secretion. Furthermore, IL-10 alone does not allow production of IgG and IgA." Because isotype switching of normal B cells occurs within secondary lymphoid organs and, more specifically, within germinal centers of secondary follicle^,*^ it may be that translation of switched isotype transcripts necessitates signals that are given within these microenvironments.24.25 As a matter of fact, T cells bearing CD40 ligand and producing IL-l0 and IL-4 have been detected within germinal centers.*'.*' Thus, it is possible that the translation blockade of some leukemic cells may be because of the lack of germinal center microenvironment components related to the altered secondary lymphoid organ structure that is observed in CLL." It may be that the defect in FLA and PAS B-CLL cells lies in their incapacity to differentiate in vivo, rather than in their inability to undergo isotype switching. However, other reports described isotype-switched variants of CLLZy and B-CLL cells expressing surface IgG."" It is likely that these variants may represent B-CLL cells that have differentiated after an encounter with the relevant signals (eg, an auto antigen, as described in some CLL cases)."
Although IL-10 has been suggested to act as a switching factor for CD40-activated B cell^,^'.^^ we cannot conclude whether the IgG and IgA production of E A and PAS B-CLL cells obtained in response to the combination of anti-CD40 and IL-10 is the result of further isotype switching in vitro and/or the induction of IgG and IgA synthesis and secretion. In this context, the secretion of IgE, whose corresponding transcripts show the original VDJ gene, in response to CD40-and IL-4 signaling shows that CLL cells can be induced to undergo isotype switching in vitro. Such a result confirms and further extends the results of a previous study that showed the secretion of IgE by B-CLL cells cultured with hydrocortisone and IL,-4.34
In conclusion, the present study has shown that B cells giving rise to CLL cells have the capacity to undergo isotype switching and differentiate into Ig-secreting cells. Whether the presence of IgG and IgA transcripts in B-CLL represents a stochastic event or, indeed, is the consequence of a specific signal remains to be determined. 
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